Kevin McHenry is a Senior Medical Science Liaison at GRAIL, a healthcare company whose mission is to detect cancer early, when it can be cured. In his role, he partners with healthcare providers and key stakeholders to advance the understanding and adoption of Galleri, a multi-cancer early detection test.

Kevin holds a background in biological sciences from the University of Illinois Chicago, where his research contributed to a U.S. patent. He brings experience across the biopharmaceutical industry and is passionate about improving patient outcomes through early detection and innovation in oncology.